cryptocurrencies of the future Related searches

Local regulators have found out the situation of institutions purchasing unlicensed financial information service products. The reporter was informed that some local securities regulatory bureaus are finding out the situation of institutions purchasing unlicensed financial information service products. The regulatory requirements require the securities fund and futures-related operating institutions within their jurisdiction to self-inspect the purchase of foreign financial information service products without the permission of the National Network Information Office. The main contents include a brief description of financial information service products, the contact telephone number and email address of foreign institutions, and so on. According to relevant regulations, the provision of financial information services by foreign institutions in China must be approved. Up to now, a total of 31 foreign institutions and 10 enterprises invested and established by foreign institutions in China have been licensed to provide financial information services. (Cailian)Pakistan KSE-100 index rose 1% to 110,164.30.Offcn Education has set up a new company in Hainan with digital technology services. According to the enterprise survey APP, recently, Hainan Offcn Zhiyuan Education Technology Co., Ltd. was established, with Li Delin as the legal representative and a registered capital of 1 million yuan. Its business scope includes: enrollment assistance services; Digital technology services, etc. Enterprise survey shows that the company is indirectly wholly-owned by Zhonggong Education.

China Overseas Development: The annual interest of "23 Zhonghai 04" will be paid on December 12th. On December 10th, China Overseas Development (00688.HK) announced that China Overseas Enterprise Development Group Co., Ltd., a wholly-owned subsidiary of the company, will pay the annual interest of "23 Zhonghai 04" on December 12th, totaling 96 million yuan. The total amount of bonds issued in this issue is 3 billion yuan, and the issuance period is 5 years. The coupon rate of bonds in this issue is 3.20%.Japan Life Insurance announced that it would spend $8.2 billion to acquire the life insurance company Resolution Life. On December 11th, Japan Life Insurance Mutual announced that it would spend about $8.2 billion to acquire the remaining 77% shares of the life insurance company Resolution Life. The transaction is expected to be completed in the second half of 2025. On the same day, Japan Life announced that it would acquire the remaining 20% shares of MLC Life Insurance from National Bank of Australia (NAB) and integrate MLC with Resolution Life.Sony Group's share price hit a record high in intraday trading, and Sony Group's share price broke through the high of 3,390 yen set in 2000, reaching a record high.

Palestinian health department: 60 wounded people in a hospital in northern Gaza are facing death danger. The Palestinian health department announced on the 11th local time that 60 wounded people in Indonesian hospital in northern Gaza are facing death danger due to lack of food and water, and the humanitarian situation in the hospital has become extremely critical. The department called on all parties concerned and humanitarian organizations to intervene immediately and provide necessary assistance.South Korea's former defense minister attempted to commit suicide in prison, and the Ministry of Justice responded that his physical condition was normal. According to Yonhap News Agency's report on the 11th, South Korea's former defense minister Jin Longxian attempted suicide in prison on the evening of 10th. In this regard, Shen Ronghai, the head of the Department of Corrections of the Korean Ministry of Justice, said in response to relevant questions that "there is no abnormality in physical condition." (World Wide Web)Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.